Cirrhosis is the most common end stage of liver diseases, and there are no effective treatment methods. Here we evaluated the effect of endothelial progenitor cell (EPC) transplantation from rat bone marrow (BM) on the development of cirrhosis induced by carbon tetrachloride (CCl 4 ). Ex vivo genera
107 Transplantation of endothelial progenitor cells improves carbon tetrachloride (CCL4)-induced liver cirrhosis in rats
β Scribed by T. Nakamura; T. Torimura; M. Sakamoto; E. Taniguchi; O. Hashimoto; K. Inoue; R. Sakata; T. Ueno; M. Sata
- Book ID
- 117374387
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 262 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In cirrhosis, intrahepatic endothelial dysfunction is one of the mechanisms involved in the increased resistance to portal blood flow and therefore in the development of portal hypertension. Endothelial nitric oxide synthase (eNOS) uncoupling due to deficiency of tetrahydrobiopterin (BH4) results in
Repopulation of the cirrhotic liver with disease-resistant hepatocytes could offer novel therapies, as well as systems for biological studies. Establishing whether transplanted hepatocytes can engraft, survive, and proliferate in the cirrhotic liver is a critical demonstration. Dipeptidyl peptidase